Cargando…
Interleukin-6 Trans-signaling: A Pathway With Therapeutic Potential for Diabetic Retinopathy
Autor principal: | Sharma, Shruti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170152/ https://www.ncbi.nlm.nih.gov/pubmed/34093244 http://dx.doi.org/10.3389/fphys.2021.689429 |
Ejemplares similares
-
Interleukin-6 trans-signaling inhibition prevents oxidative stress in a mouse model of early diabetic retinopathy
por: Robinson, Rebekah, et al.
Publicado: (2020) -
Novel Therapeutics for Diabetic Retinopathy and Diabetic Macular Edema: A Pathophysiologic Perspective
por: Bunch, Katharine L., et al.
Publicado: (2022) -
Molecular Markers of Diabetic Retinopathy: Potential Screening Tool of the Future?
por: Pusparajah, Priyia, et al.
Publicado: (2016) -
Soluble Interleukin-6 Receptor Regulates Interleukin-6-Dependent Vascular Remodeling in Long-Distance Runners
por: Villar-Fincheira, Paulina, et al.
Publicado: (2021) -
Sweet Stress: Coping With Vascular Dysfunction in Diabetic Retinopathy
por: Santiago, Ana R., et al.
Publicado: (2018)